Overview
- 94 inspections across 82 sites are on record.
- 244 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-11-21.
At a glance
Inspections
94
Sites
82
Observations
244
Career since
Apr 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| K.D. Pharma Bexbach GmbH | 21 Nov 2014 | Human Drugs | On file |
| Bayer AG | 14 Nov 2014 | Human Drugs | On file |
| Merz Pharmaceuticals GmbH | 7 Nov 2014 | Human Drugs | On file |
| Blispak, Inc. | 9 Oct 2014 | Human Drugs | View 483 → |
| LEO Pharma Inc. | 19 Sep 2014 | Human Drugs | View 483 → |
Sites inspected
K.D. Pharma Bexbach GmbHBexbach, Germany1 insp.
Bayer AGLeverkusen, Germany1 insp.
Merz Pharmaceuticals GmbHPotsdam, Germany1 insp.
Blispak, Inc.Whippany, United States1 insp.
LEO Pharma Inc.Parsippany, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sherri J Liu8 shared
Melba T Rivera Clavell6 shared
Stephen J Mottola4 shared
Lawrence R Johnson3 shared
Charles Chacko3 shared
Gianine E Tompkins3 shared
Karen E Dorazio3 shared
Kelly Doremus3 shared
Douglas C Kovacs3 shared
Liatte Krueger2 shared
Full investigator report
Get the verbatim findings behind Alberto A Viciedo's 244 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site